Rob
You just need to know that Mipomersen deal was done at Phase 2a stage. Same stage as ATL 1103 this year.
The phase 2b to approval stages of Mipomersen was using the cash from the deal in 2008 when it was at the same stage as ATL 1103.
The key is we believe a similar deal could be done with ATL1103 this year. A $325m deal plus $1.5b milestone will make ANP 's current SP look rediculous.
As for your effort to talk ANP down, hoping it to go back to pre-Phase I level, you have to realise Phase 2a is like a larger Phase 1, the success rate is very high. It is a 5 weeks trial and can commence in
6 months if funding is sorted soon.
And this is only for ATL1103. We still have ATL 1101 for cancer, ATL1102 could go to phase 2b and 3.
DYOR but stop twisting it to suit your sub 1c target.
RobYou just need to know that Mipomersen deal was done at Phase...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.015(13.0%) |
Mkt cap ! $117.2M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.5¢ | 12.0¢ | $612.7K | 4.843M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 56662 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 600000 | 2 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |